Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
Morani G, Gasparini M, Zanon F, Casali E, Spotti A, Reggiani A, Bertaglia E, Solimene F, Molon G, Accogli M, Tommasi C, Paoletti Perini A, Ciardiello C, Padeletti L. Morani G, et al. Europace. 2013 Sep;15(9):1273-9. doi: 10.1093/europace/eut032. Epub 2013 Feb 24. Europace. 2013. PMID: 23439866
Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
Ricci RP, Pignalberi C, Landolina M, Santini M, Lunati M, Boriani G, Proclemer A, Facchin D, Catanzariti D, Morani G, Gulizia M, Mangoni L, Grammatico A, Gasparini M; ClinicalService cardiological centres. Ricci RP, et al. Among authors: morani g. Heart. 2014 Jun;100(11):848-54. doi: 10.1136/heartjnl-2013-305259. Epub 2014 Mar 28. Heart. 2014. PMID: 24682569 Clinical Trial.
Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: Efficacy, safety, and impact on mortality.
Landolina M, Lunati M, Boriani G, Pietro Ricci R, Proclemer A, Facchin D, Rordorf R, Morani G, Maines M, Gasparini G, Molon G, Turrini P, Gasparini M; ClinicalService cardiological centers. Landolina M, et al. Among authors: morani g. Heart Rhythm. 2016 Feb;13(2):472-80. doi: 10.1016/j.hrthm.2015.10.022. Epub 2015 Oct 23. Heart Rhythm. 2016. PMID: 26477710 Clinical Trial.
Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP).
Forleo GB, Santini L, Giammaria M, Potenza D, Curnis A, Calabrese V, Ricciardi D, D'agostino C, Notarstefano P, Ribatti V, Morani G, Mantica M, Di Biase L, Bertaglia E, Calò L, Zanon F. Forleo GB, et al. Among authors: morani g. Europace. 2017 Jul 1;19(7):1170-1177. doi: 10.1093/europace/euw094. Europace. 2017. PMID: 27189954 Free PMC article.
Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.
Mantovani A, Rigolon R, Civettini A, Bolzan B, Morani G, Bonapace S, Dugo C, Zoppini G, Bonora E, Targher G. Mantovani A, et al. Among authors: morani g. J Endocrinol Invest. 2018 Feb;41(2):223-231. doi: 10.1007/s40618-017-0729-4. Epub 2017 Jul 15. J Endocrinol Invest. 2018. PMID: 28711969
Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
Gasparini M, Kloppe A, Lunati M, Anselme F, Landolina M, Martinez-Ferrer JB, Proclemer A, Morani G, Biffi M, Ricci R, Rordorf R, Mangoni L, Manotta L, Grammatico A, Leyva F, Boriani G. Gasparini M, et al. Among authors: morani g. Eur J Heart Fail. 2018 Oct;20(10):1472-1481. doi: 10.1002/ejhf.1117. Epub 2017 Dec 18. Eur J Heart Fail. 2018. PMID: 29251799 Free article. Clinical Trial.
61 results